Co-Culture of Murine Small Intestine Epithelial Organoids with Innate Lymphoid Cells
March 23rd, 2022
6.4K views
This protocol offers detailed instructions for establishing murine small intestine organoids, isolating type-1 innate lymphoid cells from the murine small intestine lamina propria, and establishing 3-dimensional (3D) co-cultures between both cell types to study bi-directional interactions between intestinal epithelial cells and type-1 innate lymphoid cells.
Overview
This protocol provides detailed instructions for establishing murine small intestine organoids and isolating type-1 innate lymphoid cells. It facilitates the study of bi-directional interactions between intestinal epithelial cells and type-1 innate lymphoid cells.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Cell Biology
Background
- This protocol offers a significant tool to study interactions between intestinal immune cells and the epithelium.
- It helps dissect how these interactions regulate intestinal homeostasis and inflammation.
- The system has been used to determine the role of ILC1 in the expansion of CD44-positive epithelial crypts.
- It has potential applications in understanding inflammation-mediated gastrointestinal diseases.
Purpose of Study
- To establish a controlled in vitro model for studying epithelial and immune biology.
- To explore the interactions between intestinal epithelial cells and type-1 innate lymphoid cells.
- To advance understanding of gastrointestinal diseases.
Methods Used
- Preparation of thermal cross-linking basal extracellular matrix.
- Thawing and pre-warming of tissue culture-treated plates.
- Passaging of organoids using advanced DMEM F12.
- Harvesting organoids into a 15-milliliter tube.
Main Results
- Establishment of a robust model for studying intestinal interactions.
- Insights into the role of ILC1 in epithelial crypt expansion.
- Potential advancements in understanding gastrointestinal inflammation.
- Enhanced experimental control in studying immune and epithelial biology.
Conclusions
- This protocol provides a valuable framework for future research.
- It allows for detailed investigation of intestinal immune responses.
- It contributes to the understanding of mechanisms underlying gastrointestinal diseases.
Frequently Asked Questions
What are murine small intestine organoids?
Murine small intestine organoids are 3D structures derived from mouse intestinal tissue that mimic the architecture and function of the intestine.
How do type-1 innate lymphoid cells interact with epithelial cells?
Type-1 innate lymphoid cells interact with epithelial cells to regulate immune responses and maintain intestinal homeostasis.
What is the significance of studying these interactions?
Understanding these interactions can provide insights into the mechanisms of intestinal inflammation and related diseases.
What advantages does this protocol offer?
The protocol offers experimental control and a reductionist model to study complex biological interactions in vitro.
Can this model be used for drug testing?
Yes, this model can be utilized for testing the effects of drugs on intestinal immune responses and epithelial function.
How can I access the full transcript of the protocol?
The full transcript is available through the JoVE platform, which provides access to thousands of scientific videos.
Executive Industry Relevance
Co-culturing murine small intestine epithelial organoids with innate lymphoid cells (ILCs) enables precise interrogation of epithelial-immune interactions central to mucosal homeostasis and inflammation. This reductionist 3D system provides a controlled platform for dissecting mechanisms underlying barrier integrity, regeneration, and immune modulation in the gut. The approach supports predictive confidence in early discovery and de-risks target validation for gastrointestinal disease portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic dissection of epithelial-immune signaling pathways relevant to mucosal health.
- Supports functional validation of ILC subsets in regulating epithelial barrier and regeneration.
- Facilitates hypothesis-driven exploration of immune cell contributions to disease-relevant phenotypes.
- Provides a tractable system for biological de-risking prior to in vivo studies.
Screening & Assay Development
- Establishes validated co-culture models for quantitative assessment of epithelial and immune cell responses.
- Supports reproducible measurement of molecular markers such as CD44 and ZO-1 in response to ILC modulation.
- Enables downstream analysis by immunofluorescence, flow cytometry, and gene expression profiling.
- Prepares robust biological systems for compound or cytokine screening in a physiologically relevant context.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant mechanisms of mucosal inflammation and repair.
- Provides continuity from discovery-stage mechanistic insights to preclinical model development.
- Supports identification of translational biomarkers linked to epithelial-immune crosstalk.
- De-risks advancement decisions by clarifying immune contributions to epithelial pathology.
Pipeline & Workflow Integration
This co-culture system bridges early discovery and preclinical research by enabling controlled hypothesis testing of epithelial-immune interactions. It supports lead identification and mechanistic de-risking for gastrointestinal disease programs.
- Discovery Biology: Facilitates null hypothesis testing of ILC effects on epithelial cell phenotypes and signaling.
- Screening: Provides standardized, reproducible outputs for quantitative comparison of experimental conditions.
- Analytics: Delivers multiplexed readouts via flow cytometry, immunochemistry, and RT-qPCR for robust data integration.
- Translational Research: Connects in vitro findings to in vivo models and potential biomarker strategies.
- Enterprise Reuse: Offers a modular platform adaptable to other immune or epithelial cell populations for broader R&D applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and reduces mechanistic ambiguity in mucosal biology.
- Operational Value: Standardizes co-culture protocols for reproducibility and scalability across teams.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by clarifying biological risk early.
- Portfolio Impact: Enables risk-adjusted prioritization of gastrointestinal and inflammation-focused assets.
Implementation Considerations
- Requires expertise in organoid culture, immune cell isolation, and advanced analytical techniques.
- Demands access to flow cytometry, confocal microscopy, and molecular biology infrastructure.
- Necessitates cross-team standardization of co-culture conditions and analytical endpoints.
- Adaptable to other immune or epithelial cell types with protocol optimization.
- Careful handling is essential to maintain organoid integrity and ensure reliable data.
Biopharma FAQs
Why does null hypothesis testing matter for ILC1-epithelial co-cultures?
Null hypothesis testing in ILC1-epithelial co-cultures enables rigorous evaluation of whether observed changes in epithelial markers, such as CD44 expression, are specifically attributable to ILC1 presence. This approach strengthens target validation by distinguishing true biological effects from background variability, supporting confident advancement decisions.
How does independent variable isolation fit the organoid-ILC workflow?
Isolating variables such as ILC1 subtype, cytokine exposure, or blocking antibodies within the co-culture system allows precise attribution of observed epithelial responses. This control is critical for dissecting mechanistic pathways and informing early discovery pipeline progression.
What do quantitative dependent variable measurements enable in this system?
Quantitative measurements of markers like CD44, ZO-1, and gene expression via flow cytometry and RT-qPCR provide robust, reproducible data for comparing experimental conditions. These outputs enable teams to assess the magnitude and specificity of epithelial responses to immune modulation.
Why are replication requirements important for cross-functional collaboration?
Replication of co-culture experiments ensures that findings are reproducible and transferable across teams, supporting cross-functional confidence in data quality. This is essential for integrating results into broader R&D workflows and for portfolio-level decision making.
What statistical analysis capabilities are required before implementation?
Robust statistical analysis, including appropriate controls and quantitative comparisons, is necessary to validate observed effects and support data-driven conclusions. Teams must ensure analytical rigor to enable reliable interpretation and downstream application of co-culture findings.
